drugset
drugset / Trial / NCT06699355

A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Atorvastatin in Healthy Adult Participants (MK-0616-024)

NCT06699355 ↗

Phase 1 Completed 18 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverOpen-labelTreatment

Summary

The goal of this study is to learn what happens to enlicitide decanoate and atorvastatin in a healthy person's body over time. Researchers want to learn what happens to enlicitide decanoate in the body when it is given with and without another medicine called atorvastatin and what happens to atorvastatin in the body when it is given with or without enlicitide decanoate.

Timeline

Start
2023-11-08
Primary completion
2023-12-29
Completion
2023-12-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule — Oral
Subject Enlicitide Decanoate Unknown — Oral

Indications

No indication recorded.